Call to action on use and reimbursement for home blood pressure monitoring: A joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association

被引:180
|
作者
Pickering, Thomas G.
Miller, Nancy Houston
Ogedegbe, Gbenga
Krakoff, Lawrence R.
Artinian, Nancy T.
Goff, David
机构
关键词
AHA Scientific Statements; blood pressure; hypertension; patients;
D O I
10.1097/01.JCN.0000317429.98844.04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Home blood pressure monitoring (HBPM) overcomes many of the limitations of traditional office blood pressure (BP) measurement and is both cheaper and easier to perform than ambulatory BP monitoring. Monitors that use the oscillometric method are currently available that are accurate, reliable, easy to use, and relatively inexpensive. An increasing number of patients are using them regularly to check their BP at home, but although this has been endorsed by national and international guidelines, detailed recommendations for their use have been lacking. There is a rapidly growing literature showing that measurements taken by patients at home are often lower than readings taken in the office and closer to the average BP recorded by 24-hour ambulatory monitors, which is the BP that best predicts cardiovascular risk. Because of the larger numbers of readings that can be taken by HBPM than in the office and the elimination of the white-coat effect (the increase of BP during an office visit), home readings are more reproducible than office readings and show better correlations with measures of target organ damage. In addition, prospective studies that have used multiple home readings to express the true BP have found that home BP predicts risk better than office BP (Class IIa; Level of Evidence A), This call-to-action article makes the following recommendations: (1) It is recommended that HBPM should become a routine component of BP measurement in the majority of patients with known or suspected hypertension; (2) Patients should be advised to purchase oscillometric monitors that measure BP on the upper arm with an appropriate cuff size and that have been shown to be accurate according to standard international protocols. They should be shown how to use them by their healthcare providers; (3) Two to 3 readings should be taken while the subject is resting in the seated position, both in the morning and at night, over a period of 1 week. A total of :12 readings are recommended for making clinical decisions; (4) HBPM is indicated in patients with newly diagnosed or suspected hypertension, in whom it may distinguish between white-coat and sustained hypertension. if the results are equivocal, ambulatory BP monitoring may help to establish the diagnosis; (5) In patients with prehypertension, HBPM may be useful for detecting masked hypertension; (6) HBPM is recommended for evaluating the response to any type of antihypertensive treatment and may improve adherence; (7) The target HBPM goal for treatment is < 135/85 mm Hg or < 130/80 mm Hg in high-risk patients; (8) HBPM is useful in the elderly, in whom both BP variability and the white-coat effect are increased; (9) HBPM is of value in patients with diabetes, in whom tight BP control is of paramount importance; (10) Other populations in whom HBPM may be beneficial include pregnant women, children, and patients with kidney disease; and (11) HBPM has the potential to improve the quality of care while reducing costs and should be reimbursed.
引用
收藏
页码:299 / 323
页数:25
相关论文
共 50 条
  • [31] Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
    Cluett, Jennifer L.
    Blazek, Olivia
    Brown, Angela L.
    East, Cara
    Ferdinand, Keith C.
    Fisher, Naomi D. L.
    Ford, Cassandra D.
    Griffin, Karen A.
    Mena-Hurtado, Carlos I.
    Sarathy, Harini
    Vongpatanasin, Wanpen
    Townsend, Raymond R.
    HYPERTENSION, 2024, 81 (10) : e135 - e148
  • [32] Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association
    Morris, Shaine A.
    Flyer, Jonathan N.
    Yetman, Anji T.
    Quezada, Emilio
    Cappella, Elizabeth S.
    Dietz, Harry C.
    Milewicz, Dianna M.
    Ouzounian, Maral
    Rigelsky, Christina M.
    Tierney, Seda
    Lacro, Ronald V.
    CIRCULATION, 2024, 150 (11) : e228 - e254
  • [33] Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association
    Shaw, Leslee J.
    Blankstein, Ron
    Jacobs, Jill E.
    Leipsic, Jonathon A.
    Kwong, Raymond Y.
    Taqueti, Viviany R.
    Beanlands, Rob S. B.
    Mieres, Jennifer H.
    Flamm, Scott D.
    Gerber, Thomas C.
    Spertus, John
    Di Carli, Marcelo F.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2017, 10 (12)
  • [34] Cardiovascular Health in African Americans A Scientific Statement From the American Heart Association
    Carnethon, Mercedes R.
    Pu, Jia
    Howard, George
    Albert, Michelle A.
    Anderson, Cheryl A. M.
    Bertoni, Alain G.
    Mujahid, Mahasin S.
    Palaniappan, Latha
    Taylor, Herman A., Jr.
    Willis, Monte
    Yancy, Clyde W.
    CIRCULATION, 2017, 136 (21) : E393 - E423
  • [35] Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association
    Mital, Seema
    Musunuru, Kiran
    Garg, Vidu
    Russell, Mark W.
    Lanfear, David E.
    Gupta, Rajat M.
    Hickey, Kathleen T.
    Ackerman, Michael J.
    Perez, Marco V.
    Roden, Dan M.
    Woo, Daniel
    Fox, Caroline S.
    Ware, Stephanie
    CIRCULATION-CARDIOVASCULAR GENETICS, 2016, 9 (05) : 448 - 467
  • [36] Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
    Iadecola, Costantino
    Yaffe, Kristine
    Biller, Jose
    Bratzke, Lisa C.
    Faraci, Frank M.
    Gorelick, Philip B.
    Gulati, Martha
    Kamel, Hooman
    Knopman, David S.
    Launer, Lenore J.
    Saczynski, Jane S.
    Seshadri, Sudha
    Al Hazzouri, Adina Zeki
    HYPERTENSION, 2016, 68 (06) : E67 - E94
  • [37] Palliative Pharmacotherapy for Cardiovascular Disease: A Scientific Statement From the American Heart Association
    Di Palo, Katherine E.
    Feder, Shelli
    Baggenstos, Yleana T.
    Cornelio, Cyrille K.
    Forman, Daniel E.
    Goyal, Parag
    Kwak, Min Ji
    Mcilvennan, Colleen K.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2024, 17 (08):
  • [38] Pet Ownership and Cardiovascular Risk: A Scientific Statement From the American Heart Association
    Levine, Glenn N.
    Allen, Karen
    Braun, Lynne T.
    Christian, Hayley E.
    Friedmann, Erika
    Taubert, Kathryn A.
    Thomas, Sue Ann
    Wells, Deborah L.
    Lange, Richard A.
    CIRCULATION, 2013, 127 (23) : 2353 - 2363
  • [39] Cardiovascular Health in Turner Syndrome A Scientific Statement From the American Heart Association
    Silberbach, Michael
    Roos-Hesselink, Jolien W.
    Andersen, Niels H.
    Braverman, Alan C.
    Brown, Nicole
    Collins, R. Thomas
    De Backer, Julie
    Eagle, Kim A.
    Hiratzka, Loren F.
    Johnson, Walter H., Jr.
    Kadian-Dodov, Daniella
    Lopez, Leo
    Mortensen, Kristian H.
    Prakash, Siddharth K.
    Ratchford, Elizabeth V.
    Saidi, Arwa
    van Hagen, Iris
    Young, Luciana T.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (10): : e000048
  • [40] Meditation and Cardiovascular Risk Reduction A Scientific Statement From the American Heart Association
    Levine, Glenn N.
    Lange, Richard A.
    Bairey-Merz, C. Noel
    Davidson, Richard J.
    Jamerson, Kenneth
    Mehta, Puja K.
    Michos, Erin D.
    Norris, Keith
    Ray, Indranill Basu
    Saban, Karen L.
    Shah, Tina
    Stein, Richard
    Smith, Sidney C., Jr.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (10):